Innovation Center for Minimally Invasive Technique and Device, Department of General Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310019, P.R. China.
Institute of Translational Medicine, Zhejiang University School of Medicine and Zhejiang University Cancer Center, Hangzhou, Zhejiang 310029, P.R. China.
Nucleic Acids Res. 2023 Apr 11;51(6):2740-2758. doi: 10.1093/nar/gkad116.
In CRISPR/Cas9 genome editing, the tight and persistent target binding of Cas9 provides an opportunity for efficient genetic and epigenetic modification on genome. In particular, technologies based on catalytically dead Cas9 (dCas9) have been developed to enable genomic regulation and live imaging in a site-specific manner. While post-cleavage target residence of CRISPR/Cas9 could alter the pathway choice in repair of Cas9-induced DNA double strand breaks (DSBs), it is possible that dCas9 residing adjacent to a break may also determine the repair pathway for this DSB, providing an opportunity to control genome editing. Here, we found that loading dCas9 onto a DSB-adjacent site stimulated homology-directed repair (HDR) of this DSB by locally blocking recruitment of classical non-homologous end-joining (c-NHEJ) factors and suppressing c-NHEJ in mammalian cells. We further repurposed dCas9 proximal binding to increase HDR-mediated CRISPR genome editing by up to 4-fold while avoiding exacerbation of off-target effects. This dCas9-based local inhibitor provided a novel strategy of c-NHEJ inhibition in CRISPR genome editing in place of small molecule c-NHEJ inhibitors, which are often used to increase HDR-mediated genome editing but undesirably exacerbate off-target effects.
在 CRISPR/Cas9 基因组编辑中,Cas9 对靶标的紧密且持久的结合为在基因组上进行高效的遗传和表观遗传修饰提供了机会。特别是,基于无催化活性 Cas9(dCas9)的技术已被开发出来,以实现基因组的特异性调控和实时成像。虽然 CRISPR/Cas9 切割后的靶标停留可能会改变 Cas9 诱导的 DNA 双链断裂 (DSB)修复中的途径选择,但 dCas9 紧邻断裂处停留也可能决定该 DSB 的修复途径,从而为控制基因组编辑提供了机会。在这里,我们发现将 dCas9 加载到 DSB 附近的位点可通过局部阻断经典非同源末端连接 (c-NHEJ) 因子的募集并抑制哺乳动物细胞中的 c-NHEJ 来刺激该 DSB 的同源定向修复 (HDR)。我们进一步重新利用 dCas9 近端结合,将 HDR 介导的 CRISPR 基因组编辑提高了 4 倍,同时避免了脱靶效应的恶化。这种基于 dCas9 的局部抑制剂为 CRISPR 基因组编辑中的 c-NHEJ 抑制提供了一种新策略,替代了通常用于提高 HDR 介导的基因组编辑但不希望恶化脱靶效应的小分子 c-NHEJ 抑制剂。